(NASDAQ: MBOT) Microbot Medical's forecast annual revenue growth rate of 499.64% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.02%.
Microbot Medical's revenue in 2026 is $105,000.On average, 5 Wall Street analysts forecast MBOT's revenue for 2026 to be $193,568,956, with the lowest MBOT revenue forecast at $103,702,453, and the highest MBOT revenue forecast at $246,830,644. On average, 5 Wall Street analysts forecast MBOT's revenue for 2027 to be $609,722,063, with the lowest MBOT revenue forecast at $362,018,277, and the highest MBOT revenue forecast at $775,753,452.
In 2028, MBOT is forecast to generate $1,644,194,328 in revenue, with the lowest revenue forecast at $1,388,833,755 and the highest revenue forecast at $1,897,069,804.